Business Context and Reporting Period
Company: James Hardie Industries plc
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: November 16, 2018
Reporting Period: Month of November 2018
This filing serves as a procedural report to the U.S. Securities and Exchange Commission regarding corporate governance updates. It does not contain a full financial report for the period.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing referencing corporate appointments rather than a financial results announcement.
Material Changes
No material financial changes are reported in this document. The filing discloses the following corporate actions via exhibits:
- Appointment of a Non-Executive Director (Exhibit 99.1).
- Submission of Appendix 3X - Rodriguez (Exhibit 99.2).
Guidance, Outlook, and Risks
Forward-Looking Statements: The filing includes an extensive disclaimer regarding forward-looking statements. Management notes that actual results may differ materially from projections due to various risks.
Key Risks Identified:
- Asbestos Liabilities: Risks related to prior asbestos product manufacture, contributions to the Asbestos Injuries Compensation Fund (AICF), potential shortfalls in the fund, and currency exchange impacts on asbestos liabilities.
- Legal and Regulatory: Exposure to product liability, environmental, consumer class action, and intellectual property proceedings.
- Market Conditions: Dependence on residential and commercial construction markets, housing values, interest rates, and consumer confidence in the U.S. and Asia Pacific regions.
- Operational: Supply and cost of raw materials, competition, and integration of the Fermacell business.
- Financial: Ability to renew credit facilities and manage tax liabilities.
Investor Verification Checklist
- Verify the identity and background of the newly appointed Non-Executive Director referenced in Exhibit 99.1.
- Review the most recent Form 20-F (filed May 22, 2018) for detailed financial metrics and comprehensive risk factors, as this 6-K does not contain them.
- Monitor updates regarding the Asbestos Injuries Compensation Fund (AICF) and any changes in required contributions.
- Check for subsequent filings regarding the integration of Fermacell and its impact on operations.